| 000 | 00673nam a22002052 4500 | ||
|---|---|---|---|
| 001 | hsl001006356 | ||
| 003 | DGPO | ||
| 005 | 20170826152551.0 | ||
| 008 | 170110s1970 dcu f000 0 eng d | ||
| 040 |
_aGPO _cGPO _dMvI |
||
| 086 | 0 | _aHE 20.3161/A:EP 85 | |
| 099 | _aHE 20.3161/A:EP 85 | ||
| 245 | 0 | 0 | _aAntibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. |
| 260 |
_a[Washington, D.C., _c1970] |
||
| 300 | _av. | ||
| 500 | _aReprint from v.44, no.1, Jan. 1970. | ||
| 500 | _aCRDP Program Historic Shelflist record. | ||
| 650 | 0 |
_aEpstein-Barr virus _xResearch. |
|
| 710 | 2 | _aNational Cancer Institute (U.S.) | |
| 949 |
_aBEV _bFed Docs |
||
| 999 |
_c264326 _d264326 |
||